.jpg)
The Invisible Cancer - Bringing Visibility to Neuroendocrine Cancer
The Invisible Cancer Podcast raises awareness of neuroendocrine cancer, a cancer most people have never heard of, and this lack of awareness can affect diagnosis, treatment, and care. Through real-life stories, expert insights, and practical advice, we explore the challenges patients face, from initial diagnosis to management, including the impact on mental health and ongoing follow-up.
Hosted by Lisa Walker and produced by Neuroendocrine Cancer UK, this podcast shines a light on neuroendocrine and other often-overlooked cancers, offering information, support, and connection to anyone affected.
The Invisible Cancer - Bringing Visibility to Neuroendocrine Cancer
Beyond the Lab: Unravelling Rare Cancer with Andy Hall
•
Neuroendocrine Cancer UK
•
Season 2
•
Episode 4
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this episode, Neuroendocrine Cancer UK's Campaign Lead, Lisa interviews Andy Hall, Chief Scientific Officer at RareCan—an organisation dedicated to improving outcomes for individuals with rare forms of cancer.
Join them in a thought-provoking discussion as Andy shares his journey from being a lab-based researcher, specialising in pediatric cancer biology. Delve into the world of basic research and gain a fascinating insight into the inner workings of the lab.
Discover the crucial role patients play in this process and how basic research can profoundly impact clinical practice. Get ready to be inspired by the powerful connections between research and patient care.
Further support:
Join them in a thought-provoking discussion as Andy shares his journey from being a lab-based researcher, specialising in pediatric cancer biology. Delve into the world of basic research and gain a fascinating insight into the inner workings of the lab.
Discover the crucial role patients play in this process and how basic research can profoundly impact clinical practice. Get ready to be inspired by the powerful connections between research and patient care.
Further support:
- Neuroendocrine Cancer UK
- Rarecan
- Neuroendocrine Cancer Research
- Advancing Neuroendocrine Cancer Research Campaign
